W
ABBV icon

WealthCollab’s AbbVie ABBV Stock Holding History

WealthCollab’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$87K Hold
400
– – 0.04% 144
2025
Q4 		$91.4K Sell
400
-1
-0.2% -$228 0.04% 138
2025
Q3 		$92.8K Buy
401
+42
+12% +$8.55K 0.04% 123
2025
Q2 		$66.6K Buy
359
+6
+2% +$1.11K 0.04% 150
2025
Q1 		$74K Buy
353
+5
+1% +$972 0.05% 124
2024
Q4 		$61.8K Buy
348
+128
+58% +$23.5K 0.04% 139
2024
Q3 		$43.4K Sell
220
-26
-11% -$4.85K 0.03% 177
2024
Q2 		$42.2K Sell
246
-11
-4% -$1.82K 0.03% 175
2024
Q1 		$46.8K Buy
257
+11
+4% +$1.9K 0.03% 162
2023
Q4 		$38.1K Buy
+246
New +$35.9K 0.03% 160

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

WealthCollab's ABBV Position: Q1 2026 in Review

WealthCollab held its AbbVie (ABBV) position steady in Q1 2026 at 400 shares worth $87K. The position accounts for 0.04% of the portfolio, ranked #144.

WealthCollab first reported a position in ABBV in Q4 2023 and has held it in 10 quarters since. The position peaked at $92.8K in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • WealthCollab held 400 shares of AbbVie worth $87K as of Q1 2026.
  • WealthCollab left its AbbVie share count unchanged in Q1 2026.
  • AbbVie made up 0.04% of WealthCollab's portfolio in Q1 2026, its #144 holding.
  • WealthCollab first reported a position in AbbVie in Q4 2023 and has held it in 10 quarters since.
  • WealthCollab's AbbVie position peaked at $92.8K in Q3 2025.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on WealthCollab's 13F filing for Q1 2026, filed 13 May 2026.